Global Blood Therapeutics Lands $40,700,000 Series A Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1c4a913f-ab2d-462c-b179-385d9ec3a3fa&Preview=1 -
Date
6/15/2012 -
Company Name
Global Blood Therapeutics -
Mailing Address
455 Mission Bay Blvd South San Francisco, CA 94158 -
Company Description
Global Blood Therapeutics, Inc. is a product-focused company building a pipeline of innovative, oral medicines to revolutionize the treatment of chronic blood-based diseases and severe genetic disorders for which there are currently no cures available and only extremely limited therapeutic options. -
Website
http://www.globalbloodtx.com -
Transaction Type
Venture Equity -
Transaction Amount
$40,700,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Third Rock Ventures -
Venture Investor
Undisclosed
